摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl cis-[4-cyano-4-(3-cyclopentyloxy-4-methoxyphenyl)cyclohexane- 1-carboxylate] | 153259-62-2

中文名称
——
中文别名
——
英文名称
methyl cis-[4-cyano-4-(3-cyclopentyloxy-4-methoxyphenyl)cyclohexane- 1-carboxylate]
英文别名
methyl cis-[4-cyano-4-(3-cyclopentyloxy-4-methoxyphenyl)cyclohexane-1-carboxylate];Methyl cis-[4-Cyano-4-(3cyclopentyloxy-4-methoxyphenyl)cyclohexane-1-carboxylate]
methyl cis-[4-cyano-4-(3-cyclopentyloxy-4-methoxyphenyl)cyclohexane- 1-carboxylate]化学式
CAS
153259-62-2
化学式
C21H27NO4
mdl
——
分子量
357.45
InChiKey
WUSGLEFPBNJHCW-GGYDESQDSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.14
  • 重原子数:
    26.0
  • 可旋转键数:
    5.0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.62
  • 拓扑面积:
    68.55
  • 氢给体数:
    0.0
  • 氢受体数:
    5.0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    methyl cis-[4-cyano-4-(3-cyclopentyloxy-4-methoxyphenyl)cyclohexane- 1-carboxylate] 在 lithium hydroxide 作用下, 以 四氢呋喃甲醇 为溶剂, 反应 2.0h, 生成 cilomilast
    参考文献:
    名称:
    Repurposing human PDE4 inhibitors for neglected tropical diseases: Design, synthesis and evaluation of cilomilast analogues as Trypanosoma brucei PDEB1 inhibitors
    摘要:
    A medicinal chemistry exploration of the human phosphodiesterase 4 (hPDE4) inhibitor cilomilast (1) was undertaken in order to identify inhibitors of phosphodiesterase B1 of Trypanosoma brucei (TbrPDEB1). T. brucei is the parasite which causes African sleeping sickness, a neglected tropical disease that affects thousands each year, and TbrPDEB1 has been shown to be an essential target of therapeutic relevance. Noting that 1 is a weak inhibitor of TbrPDEB1, we report the design and synthesis of analogs of this compound, culminating in 12b, a sub-micromolar inhibitor of TbrPDEB1 that shows modest inhibition of T. brucei proliferation.
    DOI:
    10.1016/j.bmcl.2014.07.063
  • 作为产物:
    描述:
    正丁基锂高氯酸 、 sodium chloride 、 mercury dichloride 作用下, 以 二甲基亚砜 为溶剂, 反应 49.33h, 生成 methyl cis-[4-cyano-4-(3-cyclopentyloxy-4-methoxyphenyl)cyclohexane- 1-carboxylate]
    参考文献:
    名称:
    1,4-Cyclohexanecarboxylates:  Potent and Selective Inhibitors of Phosophodiesterase 4 for the Treatment of Asthma
    摘要:
    Evaluation of a variety of PDE4 inhibitors in a series of cellular and in vivo assays suggested a strategy to improve the therapeutic index of PDE4 inhibitors by increasing their selectivity for the ability to inhibit PDE4 catalytic activity versus the ability to compete for high affinity [H-3]rolipram-binding sites in the central nervous system. Use of this strategy led ultimately to the identification of cis-4-cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl]cyclohexane-1 -carboxylic acid (1, SB 207499, Ariflo(TM)), a potent second-generation inhibitor of PDE4 with a decreased potential for side effects versus the archetypic first generation inhibitor, (R)-rolipram.
    DOI:
    10.1021/jm970090r
点击查看最新优质反应信息

文献信息

  • Compounds useful for treating allergic and inflammatory diseases
    申请人:SmithKline Beecham Corporation
    公开号:US05552438A1
    公开(公告)日:1996-09-03
    Novel compounds of Formula (I) ##STR1## where X.sub.4 is a substituted cyclohexane or cyclohexane group and the other radicals are defined herein. These compounds inhibit the production of Tumor Necrosis Factor and are useful in the treatment of disease states mediated or exacerbated by TNF production. The compounds of the present invention are also useful in the mediation or inhibition of enzymatic or catalytic activity of phosphodiesterase IV and are therefore useful in the treatment of disease states in need of mediation or inhibition thereof.
    化合物的新颖结构如下式(I)##STR1##其中X.sub.4是取代的环己烷或环己烷基团,其他基团在此有定义。这些化合物抑制肿瘤坏死因子的产生,并可用于治疗由TNF产生介导或加重的疾病状态。本发明的化合物还可用于介导或抑制磷酸二酯酶IV的酶活性,因此可用于治疗需要介入或抑制的疾病状态。
  • Compounds usefulfor treating allergic and inflammatory diseases
    申请人:SMITHKLINE BEECHAM CORPORATION
    公开号:EP1420011A1
    公开(公告)日:2004-05-19
    Certain compounds of formulae (I) and (IA) are disclosed for use in the treatment and prophylaxis of arthritic conditions.
    式 (I) 和 (IA) 的某些化合物 公开了用于治疗和预防关节炎的化合物。
  • COMPOUNDS USEFUL FOR TREATING ALLERGIC AND INFLAMMATORY DISEASES
    申请人:SMITHKLINE BEECHAM CORPORATION
    公开号:EP0633776B1
    公开(公告)日:2001-05-09
  • METHOD FOR TREATING MULTIPLE SCLEROSIS
    申请人:SMITHKLINE BEECHAM CORPORATION
    公开号:EP1043994A1
    公开(公告)日:2000-10-18
  • EP1043994A4
    申请人:——
    公开号:EP1043994A4
    公开(公告)日:2002-09-11
查看更多